#PLOSMedicine

Gabapentinoids found to increase risk of drug toxicity Study results have suggested that patients who take gabapentinoids are at greater risk of drug toxicity if they are also taking another medication. Publishing their findings in PLoS Medicine on 16…

Patients who take #gabapentinoids are at greater risk of #drugtoxicity if they are also taking another medication, research shows

#PLOSMedicine #drugresearch

buff.ly/epOdBzb

Next up in our 'meet the editors' is our Senior Editor, Alex Tosun ( @atosun.bsky.social). Alex handles papers in the areas of cancer, rheumatology and musculoskeletal disease, and global health 🧪 #Medsky #PLOSMedicine

Time to the meet our next editor, Academic Editor Rana Hinman (@hinmanrana.bsky.social), Professor at the University of Melbourne (@unimelb.bsky.social). Rana is a physiotherapist and clinical trialist, and specializes in osteoarthritis & musculoskeletal conditions. #MedSky #PLOSMedicine 🧪

Next up in our "meet the editors" is Academic Editor Pei Gao, Principal Investigator at Peking University, China. Pei's primary expertise lie in epidemiology and biostatistics, with a particular interest in cardiovascular disease risk prediction and decision modeling.🧪🫀 #MedSky #PLOSMedicine

Next up in our "meet the editors" is Academic Editor David Flood, Assistant Professor at the University of Michigan. David brings a wealth of expertise in internal medicine, including global non-communicable diseases such as cardiovascular disease and diabetes. 🧪 #MedSky #PLOSMedicine

Next up in our "meet the editors", it's Editor-in-Chief of PLOS Medicine, Till Bärnighausen, Director of the Heidelberg Institute of Global Health and Alexander von Humboldt Professor at the University of Heidelberg. 🧪 #MedSky #PLOSMedicine

Next up in our 'meet the editors' is Academic Editor Brooke Nichols (@brookeenichols.bsky.social), Associate Professor of Global Health at Boston University School of Public Health (@busph.bsky.social). Brooke specializes in infectious disease modeling and health economics. 🧪 #MedSky #PLOSMedicine

Over the next few weeks, as our Bluesky community grows, we will be introducing some of the PLOS Medicine Staff and Academic Editors, so that you can learn about their roles, areas of expertise, and their hopes for the journal and community. 🧪 #MedSky #PLOSMedicine #editors

Open science and transparency are our strongest tools in the fight against fraudulent publishing activities PLOS Medicine Executive Editor, Helen Lumbard, and Senior Editor, Front Section, Daniel Routledge, call for the scientific community to tackle research fraud and paper mills head on by creating robust...

In our latest Editorial, PLOS Medicine Executive Editor Helen Lumbard and I call for the scientific community to tackle research fraud and paper mills head on by creating robust systems of data sharing and transparency 🧪 #PLOSMedicine #datasharing #openscience
@plos.org

📄➡️ plos.io/4nDKQ2c

Exciting first day at #ERSCongress in Amsterdam and hearing all the updates in #respiratorymedicine. Can you see your study in #PLOSMedicine? If so, please reach out! #ERS2025 @plos.org

Reductions in development assistance for health funding threaten decades of progress in Africa Countries across Africa face health crises driven by aid cuts, shifting demography, and infectious and environmental threats. Renewed public health strategies, smarter investment, and stronger surveil...

Check out this new Perspective by #PLOSMedicine academic editor @petermacp.bsky.social and colleagues on the devastating effects on progress of health funding cuts in Africa:
journals.plos.org/plosmedicine...
@plos.org

Institutional dashboards on clinical trial transparency f... Author summary Why was this study done? Clinical trials...

#PLOSMedicine: Institutional dashboards on clinical trial transparency for University Medical Centers: A case ... https://dx.plos.org/10.1371/journal.pmed.1004175

Occurrence and transmission potential of asymptomatic and... Diana Buitrago-Garcia and co-workers present a systematic...

#PLOSMedicine: Occurrence and transmission potential of asymptomatic and presymptomatic SARS-CoV-2 infections ... https://dx.plos.org/10.1371/journal.pmed.1003346

New in @PLOSMedicine with @akesselheim @PORTAL_Research: The next forum for unraveling FDA off-label marketing rules: State and federal legislatures #PLOSMedicine

#PLOSMedicine: Public versus internal conceptions of addiction: An analysis of internal Philip Morris documents via @PLOSMedicine

Multimorbidity in patients with heart failure from 11 Asi... Using data from the ASIAN-HF Registry, Carolyn Lam and co...

#PLOSMedicine: Multimorbidity in patients with heart failure from 11 Asian regions: A prospective cohort study using the ASIAN-HF registry

http://dx.plos.org/10.1371/journal.pmed.1002541

Comorbidity health pathways in heart failure patients: A ... Using cross-sectional data from the Swedish Heart Failure...

#PLOSMedicine: Comorbidity health pathways in heart failure patients: A sequences-of-regressions analysis using cross-sectional data from 10,575 patients in the Swedish Heart Failure Registry

http://dx.plos.org/10.1371/journal.pmed.1002540

Cerebral white matter disease and functional decline in o... Using data from the Northern Manhattan Study, Mandip and ...

#PLOSMedicine: Cerebral white matter disease and functional decline in older adults from the Northern Manhattan Study: A longitudinal cohort study

http://dx.plos.org/10.1371/journal.pmed.1002529

Role of heme in lung bacterial infection after trauma hem... Rakesh Patel and colleagues use a mouse model of trauma a...

#PLOSMedicine: Role of heme in lung bacterial infection after trauma hemorrhage and stored red blood cell transfusion: A preclinical experimental study

http://dx.plos.org/10.1371/journal.pmed.1002522

Prevalence of sexually transmitted infections and bacteri... In a meta-analysis of observational studies and randomize...

#PLOSMedicine: Prevalence of sexually transmitted infections and bacterial vaginosis among women in sub-Saharan Africa: An individual participant data meta-analysis of 18 HIV prevention studies

http://dx.plos.org/10.1371/journal.pmed.1002511

Newest@MEIatUCSF "Regional initiatives for malaria elimination:Building and maintaining partnerships" #PLOSMedicine

Genetic assessment of age-associated Alzheimer disease ri... Rahul Desikan and colleagues use genetic and epidemiologi...

Wow--what a breakthrough study.

#PLOSMedicine: Genetic assessment of age-associated Alzheimer disease risk http://dx.doi.org/10.1371/journal.pmed.1002258

Why Most Clinical Research Is Not Useful John Ioannidis argues that problem base, context placement, information gain, pragmatism, patient centeredness, value for money, feasibility, and transparency define useful clinical research. He suggests most clinical research is not useful and reform is overdue.

#PLOSMedicine: Why Most Clinical Research Is Not Useful

A Taxpayer-Funded Clinical Trials Registry and Results Da... It already exists within the US Food and Drug Administrat...

For pre-FDAAA trial results #PLOSMedicine: A Taxpayer-Funded Clinical Trials Registry and Results Database http://dx.doi.org/10.1371/journal.pmed.0010060

x.com

Also from https://x.com/METRICStanford
#PLOSMedicine: Four Proposals to Help Improve the Medical Research Literature http://dx.plos.org/10.1371/journal.pmed.1001864

#PLOSMedicine: Publication Bias in Antipsychotic Trials

How to Make More Published Research True In a 2005 paper that has been accessed more than a millio...

#PLOSMedicine: How to Make More Published Research True http://dx.plos.org/10.1371/journal.pmed.1001747 #goodreads